Difference between revisions of "Aripiprazole-Risperidone LA"

From Psychiatrienet
Jump to: navigation, search
 
(One intermediate revision by the same user not shown)
Line 6: Line 6:
 
* '''Week 6:''' {{Stop}}
 
* '''Week 6:''' {{Stop}}
 
| start = {{StartDepot}}
 
| start = {{StartDepot}}
 
+
| info = {{ImproveCognition}}
| view =  
+
| view = StopArip6WeeksStartDepotRisp.jpg
| info =  
 
 
}}
 
}}

Latest revision as of 09:25, 11 February 2010

Ariprazole
Type Antipsychotic
Group Atypical AP
Other use moodstabilizer
links
EMEA abilify
PubChem 60975
PubMed Ariprazole
Kompas (Dutch) Ariprazole
Wikipedia Ariprazole
Risperidone
long acting
Type Antipsychotic
Group Atypical AP
links
Medscape Risperidone
PubChem 5073
PubMed Risperidone
Kompas (Dutch) Risperidone
Wikipedia Risperidone

Switch medication from Aripiprazole to Risperidone_LA.[1] [2]

Nietinrijdenbord.png Stop Aripiprazole
  • Week 1-5: Continue drug at usual dose
  • Week 6: Stop drug
Eenrichtingbord.png Start Risperidone_LA
  • Day 1: Start depot according general dosing advice (Dotted line in graph)
Infobord.png More information
  • Cognitive functions could improve after this switch.[3]
    StopArip6WeeksStartDepotRisp.jpg
Nietinrijdenbord.png — Aripiprazole
Eenrichtingbord.png — Risperidone_LA


  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
  3. Kim SW et al. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.. Hum Psychopharmacol. 2009 Oct;24(7):565-73.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.